This company has been marked as potentially delisted and may not be actively trading. NYSE:ALR Alere (ALR) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Alere Stock (NYSE:ALR) 30 days 90 days 365 days Advanced Chart Get Alere alerts:Sign Up Key Stats Today's Range$1.32▼$1.3250-Day Range N/A52-Week Range$34.41▼$51.00VolumeN/AAverage Volume40,839 shsMarket Capitalization$43.05 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Alere Inc. is a provider of health information through diagnostic tests. The Company's segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The consumer diagnostics segment consists primarily of manufacturing operations related to its role as the exclusive manufacturer of products for SPD Swiss Precision Diagnostics (SPD), its joint venture with The Procter & Gamble Company (P&G). The Company's professional diagnostic solutions allow patients and their healthcare providers to work together to manage patients' conditions over the continuum of care, from the hospital to home. The Company offers lines of drugs-of-abuse tests, reagent systems and laboratory testing options. Read More Receive ALR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alere and its competitors with MarketBeat's FREE daily newsletter. Email Address ALR Stock News HeadlinesAlerisLife and Five Star Senior Living Awarded Great Place to Work® CertificationApril 11, 2024 | businesswire.comAlro SA ALRDecember 27, 2023 | morningstar.comMA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big Banks have found a way to use a new asset as if it were cash. Not stocks. Not bonds. Not even the U.S. dollar. They now trust this asset more than the traditional financial system itself.July 2 at 2:00 AM | American Alternative (Ad)Alere (ALR) Stock Plummets, Rejects Abbott's Request to End MergerApril 18, 2023 | thestreet.comTrek's latest aluminium Émonda ALR is lighter and racier than beforeApril 9, 2023 | yahoo.comABP Acquisition to Acquire AlerisLife for $1.31 Per ShareFebruary 3, 2023 | finance.yahoo.comAlerisLife Inc. Announces Third Quarter 2022 ResultsNovember 2, 2022 | finance.yahoo.comAlerisLife Announces the Appointment of Philip Benjamson as a Senior Vice President and Chief Operating OfficerOctober 17, 2022 | finance.yahoo.comSee More Headlines ALR Stock Analysis - Frequently Asked Questions How were Alere's earnings last quarter? Alere Inc. (NYSE:ALR) released its quarterly earnings results on Friday, November, 4th. The medical research company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.54 by $0.35. The firm's revenue was down 3.6% compared to the same quarter last year. What other stocks do shareholders of Alere own? Based on aggregate information from My MarketBeat watchlists, some other companies that Alere investors own include Morgan Stanley (MS), HeartBeam (BEAT), Abbott Laboratories (ABT), Edwards Lifesciences (EW), FireEye (FEYE), Twitter (TWTR) and AEGR (AEGR). Company Calendar Last Earnings11/04/2016Today7/02/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Skilled nursing care facilities Sub-IndustryHealth Care Supplies Current SymbolNYSE:ALR CIK1145460 Webwww.alere.com Phone+1-781-6473900Fax617-796-8385Employees10,400Year FoundedN/AProfitability EPS (Trailing Twelve Months)($1.20) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$29.92 million Net Margins-5.34% Pretax Margin-5.29% Return on Equity-20.78% Return on Assets-9.02% Debt Debt-to-Equity Ratio0.45 Current Ratio1.58 Quick Ratio1.58 Sales & Book Value Annual Sales$934.59 million Price / Sales0.05 Cash FlowN/A Price / Cash FlowN/A Book Value$5.72 per share Price / Book0.23Miscellaneous Outstanding Shares32,610,000Free Float29,870,000Market Cap$43.05 million OptionableOptionable Beta0.85 Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (NYSE:ALR) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alere Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alere With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.